Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Subscribe to see Deep Cell Industries Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Deep Cell Industries Inc. is a biotechnology company headquartered in United States. It has raised at least $1.2M across the 4 funding rounds on record. Its most recent funding round raised $661,450 in December 2020. Xcout tracks 4 named people at Deep Cell Industries Inc., including Kevin Farrell (COO).
At least $1.2M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $661,450 | — | |
| SEC Form D filing | $55,000 | — | |
| SEC Form D filing | $25,000 | — | |
| SEC Form D filing | $410,200 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Deep Cell Industries Inc.'s closest competitors — see the full list of competitors and alternatives →
QuantumCyte, Inc. operates in the biotechnology research industry, focusing on specialized cellular and tissue analysis solutions. Founded in 2013, the company is headquartered in Fremont, California.
Animantis LLC is a computational biology company that uses computer vision to measure cellular behavior at the single-cell level. Its platform is designed for researchers to capture dynamic cellular processes in order to better understand disease biology and identify treatments.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Techcyte, Inc. is a software and digital pathology company headquartered in Orem, Utah, that provides an artificial intelligence platform for anatomic and clinical pathology workflows.
PathAI, Inc. is a healthcare technology company that develops artificial intelligence and machine-learning tools for digitizing and analyzing pathology images. It serves biopharmaceutical companies, research organizations, and pathology laboratories by supporting drug development, clinical trials, and diagnostic workflows.
Vara provides CE-marked artificial intelligence software designed for European breast cancer screening and diagnostics. The company's platform assists radiologists and screening programs with case triage, automated reporting, and lesion detection to improve early cancer detection and workflow efficiency.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.